That’s what this drug company is trying to do. It probably would be better to spend their resources trying to find something new, rather than repackaging old drugs (case in point: BiDil).
Similar Posts:
- Should consumer prescription drug ads be reined in?
- The risk of death from OxyContin and other narcotic drugs
- Do drug companies and the pharma industry deserve to be villains?
KevinMD.com on Facebook
Comments on this entry are closed.